3Coresh J,Astor BC,Greene T,et al.Prevalence of chronic kidney disease and decreased kidney function in the adult US population:Third National Health and Nutrition Examination Survey[J].Am J Kidney Dis,2003,41(1):1-12.
4Fishbane S,Chittineni H,Packman M,et al.Oral paricalcitol in the treatment of patients with CKD and proteinuria:a randomized trial[J].Am Jou Kid Dis,2009,54(4):647-652.
5Csaba P,Kovesdy MD,Shahram A,et al.Association of activated vitamin D treatment and mortality in chronic kidney disease[J].Arch Intern Med,2008,168(4):397-403.
6Pilz S,Drechsler C,Obermayer-Pietseh B,et al.Vitamin D deficiency is associated with sudden cardiac death,combined cardiovascular events,and mortality in haemodialysis patients[J].Eur Heart J,2010,31(18):2253-2261.
7Sugiura S,Inaguma D,Kitagawa A,et al.Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events[J].Clin Exp Nephrol,2010,14(1):43-50.
8Tamez H,Zoccali C,Packham D,et al.Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease[J].Am Heart J,2012,164(6):902-909.
9Wolf M,Teng M,Ofsthun MN,et al.Activated injectable vitamin D and hemodialysis survival:a historical cohort study[J].J Am Soc Nephrol,2005,16(4):1115-1125.
10Randomised placebo-controlled trial of effect of ramipril on declinein glomerular filtration rate and risk of terminal renal failure in proteinuric,non-diabetic nephropathy.The GISEN Group(Gruppo Italiano di Studi Epidemiologici in Nefrologia)[J].Lancet,1997,349(9069):1857-1863.